MA26980A1 - Antagonistes des recepteurs d'histamine. - Google Patents

Antagonistes des recepteurs d'histamine.

Info

Publication number
MA26980A1
MA26980A1 MA27233A MA27233A MA26980A1 MA 26980 A1 MA26980 A1 MA 26980A1 MA 27233 A MA27233 A MA 27233A MA 27233 A MA27233 A MA 27233A MA 26980 A1 MA26980 A1 MA 26980A1
Authority
MA
Morocco
Prior art keywords
receptor antagonists
histamine receptor
histamine
receptor
antagonist
Prior art date
Application number
MA27233A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26980A1 publication Critical patent/MA26980A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Antagonistes des récepteurs d'histamine La présente invention propose une association (a) d'un antagoniste des récepteurs d'histamine H1 et (b) d'un antagoniste qui est au moins 10 fois plus sélectif pour le récepteur d'histamine H4 que pour le récepteur d'histamine H3, des compositions la contenant ainsi que leurs utilisations.
MA27233A 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine. MA26980A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
MA26980A1 true MA26980A1 (fr) 2004-12-20

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27233A MA26980A1 (fr) 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine.

Country Status (32)

Country Link
EP (1) EP1353657A1 (fr)
JP (1) JP2004517883A (fr)
KR (1) KR20030069216A (fr)
CN (1) CN1486178A (fr)
AP (1) AP2002002401A0 (fr)
AR (1) AR032101A1 (fr)
BG (1) BG107834A (fr)
BR (1) BR0206502A (fr)
CA (1) CA2435121A1 (fr)
CR (1) CR6983A (fr)
CZ (1) CZ20031853A3 (fr)
DO (1) DOP2002000325A (fr)
EA (1) EA200300537A1 (fr)
EC (1) ECSP034692A (fr)
EE (1) EE200300335A (fr)
GB (1) GB0101223D0 (fr)
GT (1) GT200200003A (fr)
HU (1) HUP0302767A2 (fr)
IL (1) IL156087A0 (fr)
IS (1) IS6818A (fr)
MA (1) MA26980A1 (fr)
MX (1) MXPA03006408A (fr)
NO (1) NO20033223L (fr)
OA (1) OA12440A (fr)
PA (1) PA8537101A1 (fr)
PL (1) PL362793A1 (fr)
PY (1) PY0200477A (fr)
SK (1) SK8572003A3 (fr)
SV (1) SV2003000849A (fr)
TN (1) TNSN02003A1 (fr)
WO (1) WO2002056871A2 (fr)
ZA (1) ZA200304180B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
CA2497788A1 (fr) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
PL2858647T3 (pl) 2012-06-08 2018-10-31 Sensorion Inhibitory receptora h4 do leczenia szumów usznych
CN119823227B (zh) * 2025-01-14 2025-07-04 广州迪卡德营养科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
HUP0302767A2 (hu) 2003-11-28
DOP2002000325A (es) 2003-01-31
IS6818A (is) 2003-05-15
EE200300335A (et) 2003-12-15
CA2435121A1 (fr) 2002-07-25
PL362793A1 (pl) 2004-11-02
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (fr) 2002-07-25
NO20033223D0 (no) 2003-07-16
JP2004517883A (ja) 2004-06-17
GB0101223D0 (en) 2001-02-28
PY0200477A (es) 2004-06-01
PA8537101A1 (es) 2002-08-29
SK8572003A3 (en) 2004-07-07
BR0206502A (pt) 2003-10-21
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
ECSP034692A (es) 2003-08-29
MXPA03006408A (es) 2003-10-15
EA200300537A1 (ru) 2004-02-26
OA12440A (en) 2006-05-22
NO20033223L (no) 2003-07-16
SV2003000849A (es) 2003-01-13
AR032101A1 (es) 2003-10-22
ZA200304180B (en) 2004-06-15
EP1353657A1 (fr) 2003-10-22
KR20030069216A (ko) 2003-08-25
CZ20031853A3 (cs) 2004-07-14
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19

Similar Documents

Publication Publication Date Title
EP1467730A4 (fr) Ligands non steroidiens pour le recepteur des corticoides, compositions et utilisations desdits ligands
AU9393601A (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
WO1999048523A3 (fr) Antagonistes de mediateurs inflammatoires
MXPA04001224A (es) Agentes para incrementar la respuesta inmune.
MY135957A (en) Hard precious metal alloy member and method of manufacturing the same
DE60138228D1 (de) Metallothermische reduktion von oxiden feuerfester metalle
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
FR2863825B1 (fr) Solutions de cipc et d'un terpene ou d'une huile terpenique et leurs utilisations pour le traitement antigerminatif de bulbes ou tubercules
TNSN02003A1 (fr) Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.
SE0302370D0 (sv) Delay compositions and detonation delay devices utilizing same
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
DE60015187D1 (de) Urotensin-ii rezeptorantagonisten
DK1546067T3 (da) Rygesammensætning
IL160272A0 (en) Pharmaceutical compositions containing a pde4 or a pde3/4 inhibitor and a leukotriene receptor antagonist
WO2002089740A3 (fr) Sulfonamides
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
FR2791661B1 (fr) Nouvelles compositions d'oxydes metalliques, des capteurs semi-conducteurs prepares a partir d'une telle composition et leurs utilisations pour la detection des gaz.
FR2860436B1 (fr) Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire
DE60212130D1 (en) Carvedilolpolymorph
DE50212676D1 (de) Exopolysaccharidproduktion
ATE346023T1 (de) Monolithisch aufgebauter, basischer, feuerfester keramischer hohlkörper
ATE273792T1 (de) Verbundelemente enthaltend bitumen
DE60102704D1 (de) Trioxepan verbindungen